ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Achilles Therapeutics PLC

Achilles Therapeutics PLC (ACHL)

0.863
0.0235
(2.80%)
Closed July 13 4:00PM
0.863
0.00
(0.00%)
After Hours: 4:12PM

Achilles Therapeutics PLC Financial Summary

The current ACHL market cap is 35.45M. The company's latest EPS is USD and P/E is N/A.

Quarter End Mar 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.09M
Operating Income -17.46M
Net Income -17.51M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0531k3.13M7.32M6.08M
Operating Income -13.76M-33.2M-61.06M-71.13M-66.78M
Net Income -13.99M-33.2M-61.1M-71.18M-69.67M
Quarter End Mar 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 207.64M
Total Liabilities 22.46M
Total Equity 185.17M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 105.21M218.92M317.11M220.36M161.46M
Total Liabilities 3.86M29.55M27.58M23.31M19.09M
Total Equity 101.35M189.37M289.53M197.04M142.37M
Quarter End Mar 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating N/A
Investing N/A
Financing N/A
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -14.14M-25.25M-59.28M-59.54M-48.45M
Investing -942k-11.85M-7.63M-7.51M-1.1M
Financing 93.62M113.7M160.76M1,0009k
Market Cap 35.45M
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 41.08M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.09 (9.74%)

Company Info

Company Name Achilles Therapeutics PLC
Address 245 hammersmith road
london W6 8PW
Website https://www.achillestx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock